Reported about 14 hours ago
China's control over the global supply of active pharmaceutical ingredients (APIs) renders it a formidable player in US trade negotiations. As the US grapples with its reliance on Chinese pharmaceuticals, concerns arise over potential leverage that Beijing might exert during trade discussions. Despite no direct threats to halt drug supplies, experts warn that the escalating trade war could lead China to weaponize its influence in the medical sector. Both countries are exploring ways to enhance supply chain resilience while navigating the intricate dynamics of their economic relationship.
Source: YAHOO